UBS Group »

Inhibrx shares owned by UBS Group

Quarter-by-quarter ownership of Inhibrx (INBX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Inhibrx

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.1M 81k 38.00
2023-09-30 $698k 38k 18.36
2023-06-30 $47k 1.8k 25.96
2023-03-31 $924k 49k 18.87
2022-12-31 $2.2M 89k 24.64
2022-09-30 $319k 18k 17.90
2022-03-31 $721k 32k 22.29
2021-12-31 $1.6M 37k 43.67
2021-03-31 $51k 2.5k 20.22
2020-12-31 $64k 1.9k 33.23
2020-09-30 $20k 1.1k 18.40